Page last updated: 2024-11-07

terephthalate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

terephthalate(2-) : A dicarboxylic acid dianion obtained by the deprotonation of the carboxy groups of terephthalic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID154269
CHEBI ID30043
MeSH IDM0057614

Synonyms (14)

Synonym
3198-30-9
1,4-benzenedicarboxylate
terephthalate(2-)
CHEBI:30043
benzene-1,4-dicarboxylate
1,4-benzenedicarboxylic acid, ion(2-)
1,4-benzenecarboxylic acid
benzene para dicarboxylic acid
terephthalate ,
1,4-bezenedicarboxylic acid
KKEYFWRCBNTPAC-UHFFFAOYSA-L
1,4-benzene dicarboxylate
DTXSID70185813
Q27104106
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dicarboxylic acid dianionA carboxylic acid dianion obtained by deprotonation of both carboxy groups of any dicarboxylic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
L-glutamate degradation IX (via 4-aminobutanoate)234
4-toluenecarboxylate degradation49
terephthalate degradation410
polyethylene terephthalate degradation25

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's14 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]